Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Bronchiectasis
    • Pulmonary Fibrosis
  • Rheumatology
    • Sjögren Disease
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
    • Reproductive Health
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Urology

Latest News

person touching lower back - Pormezz - stock.adobe.com
October 7th 2026
Sacral Neuromodulation Still Seen as OAB Gold Standard in Review
By Giuliana Grossi

Sacral neuromodulation is still considered the gold standard for refractory overactive bladder, with tibial nerve stimulation a less invasive option.

Woman sleeping | Image Credit: DavidPrado - stock.adobe.com
September 30th 2026

Weekend Catch-Up Sleep Linked to Lower Odds of Overactive Bladder

By Brooke McCormick
Man with urinary incontinence | Image Credit: eddows - stock.adobe.com
September 29th 2026

Vibegron Outranks Mirabegron, Tolterodine on Several OAB Measures

By Brooke McCormick
Overactive bladder | Image Credit: syahrir - stock.adobe.com
September 29th 2026

Inflammation Tied to Overactive Bladder Odds, Partly via Adiposity

By Brooke McCormick
Overactive bladder | Image Credit: Andrii - stock.adobe.com
September 25th 2026

Overactive Bladder Predictors in Women Extend Beyond Age, BMI

By Brooke McCormick
Advertisement

Advertisement
Advertisement
Advertisement

Trending on AJMC

1

5 Things to Know if Retatrutide Is Classified as a Biologic

2

FDA Approves First Symptomatic Dermographism Treatment

3

FDA Approves Tucatinib Maintenance for HER2+ Metastatic Breast Cancer

4

Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble

5

As Mantle Cell Lymphoma Risk Tools Advance, Access Lags Behind

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text